Its braces might be invisible but Align Technology’s (ALGN) gains are not.
Getty Images The maker of transparent braces and other dental products reported earnings of 42 cents a share, week above analyst forecasts for a 30 cent profit. Revenue, meanwhile, rose to $164.5 million, above the $158.6 million forecast.
William Blair’s John Kreger and team are impressed:
We are encouraged by the strong results, which stand in stark contrast to second half 2012 when volume growth and margins declined unexpectedly. Align’s Invisalign is clearly gaining market share, generating 16% unit growth in an environment where overall orthodontic procedures are essentially flat by our estimates.
Stifel’s Jonathan Block and Ethan Roth can barely contain their excitement. They write:
Our entire 2014 leverage thesis played out in 3Q13 as ALGN significantly beat EPS numbers…yet we were silly enough to make a cautious call in front of the quarter. That said, we think our 2014 $1.66 versus the Street's $1.53 should no longer be viewed as an "unrealistic expectation" and we believe consensus likely brings their estimates up to us….overnight. Align seems to be in the sweet spot as past investments (APAC, N.A. sales reps) are starting to pay off and new innovations (SmartTrack) are resonating with docs and helping to drive utilization higher. We are raising our 2014 and 2015 EPS estimates. Reiterate Buy and increase PT from $54 to $57.
Cantor Fitzgerald’s Jeremy Feffer upgrades Aligns shares to Buy from Hold:
After seemingly hitting bottom in 3Q:12, ALGN has taken concrete steps to revitalize its North American GP dentist segment, stabilize/improve pricing, and build a formidable O-U.S. sales and training operation, all of which are paying dividends. With better overall volume trends, the ClearCorrect ITC victory, and the Realine launch, we see plenty of runway for continued outperformance.
Shares of Align have surged 24% to $57 at 12:37 p.m. Sirona Dental Systems (SIRO) has risen 0.8% to $69.61, Dentsply International (XRAY) is up 0.1% at $45.44, Integra Lifesciences (IART) has gained 0.4% to $44.23 and Danaher (DHR) has fallen 0.3% to $72.13.
No comments:
Post a Comment